Not all kidney cancers behave the same, with wildly different responses to immunotherapy or other treatments—and wildly different outcomes for patients as a result.
Not all kidney cancers behave the same, with wildly different responses to immunotherapy or other treatments—and wildly different outcomes for patients as a result.
